NCT04528680: Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
- State
- Under way
- Phase
- Phase 1 and Phase 2
- People
- 57 planned
- Started
- 29 Oct 2020
- Primary completion
- 31 Dec 2027
- Arms
- SC9/ABX (phase 1); SC9/ABX/Carboplatin (phase 2)
- Results
- None posted
- 27 Aug 2020: Trial registered
- 29 Oct 2020: Trial started